10 patents currently held
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Jun 2030. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
1
Ending by 2030
Jun 2030
Next term end
9
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Apr 2034 · High confidence
Also notable
Ends Sep 2039 · High confidence
Also notable
Ends Feb 2041 · High confidence
Also notable
Ends Aug 2039 · High confidence
Also notable
Ends Jun 2030 · High confidence
Also notable
Ends Aug 2041 · High confidence
Also notable
Ends Apr 2042 · High confidence
Lithium Nickel Cobalt Manganese Composite Oxide Cathode Material
US 9,293,766
Granted 2016 and renewed at every maintenance window due so far. Protection runs to 2034.
Forgery Detection System and Its Method for Falsified Biomedical Experiment Images
US 11,017,516
Granted 2021. Computed term ends 2039.
Human-Computer Interactive Rehabilitation System
US 11,497,440
Granted 2022. Computed term ends 2041.
Speaker Diaphragm Structure
US 10,771,900
Granted 2020. Computed term ends 2039.
Use of Clerodendrum SP. for Treating Tic Disorders or Psychiatric Disorders with Sensorimotor Gating Deficits
US 8,182,844
Renewed at every maintenance window since the 2012 grant; no more fees are due before its term ends in 2030.
Chemotherapy Drug-Sensitizing Method, Agent Composition and Use Thereof
US 11,583,547
Granted 2023. Computed term ends 2041.
Liquid Separation Kit
US 12,589,332
Granted 2026. Too new for citation comparison; protection runs to 2042.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Aug 27, 2027The maintenance fee for Method for Treating Hypertension by Using Compound (US 11,911,377) comes due Aug 27, 2027. Unpaid by Feb 28, 2028, it lapses early.
- 2 fees due Sep 19 to 22, 2027 · next Sep 19
Recent changes
- 1 of the patents on this record was granted since Aug 23, 2026
What they patent
The 2 largest of its 9 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Human-Computer Interactive Rehabilitation System | 2 in force | to Mar 2042 |
| Liquid Separation Kit | 1 in force | to Apr 2042 |
Patents held now
Soonest term end first.
Showing 1 to 10 of 10
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,182,844 | Use of Clerodendrum SP. for Treating Tic Disorders or Psychiatric Disorders with Sensorimotor Gating Deficits In force · High confidence | In force | High confidence | |
| US 9,293,766 | Lithium Nickel Cobalt Manganese Composite Oxide Cathode Material In force · High confidence | In force | High confidence | |
| US 10,771,900 | Speaker Diaphragm Structure held by Fu Jen Catholic University and Micro Lithography Inc. In force · High confidence | In force | High confidence | |
| US 11,017,516 | Forgery Detection System and Its Method for Falsified Biomedical Experiment Images In force · High confidence | In force | High confidence | |
| US 11,497,440 | Human-Computer Interactive Rehabilitation System In force · High confidence | In force | High confidence | |
| US 11,583,547 | Chemotherapy Drug-Sensitizing Method, Agent Composition and Use Thereof In force · High confidence | In force | High confidence | |
| US 11,911,377 | Method for Treating Hypertension by Using Compound In force · High confidence | In force | High confidence | |
| US 12,589,332 | Liquid Separation Kit In force · High confidence | In force | High confidence | |
| US 11,934,014 | Color-Light Generation System and Method of Using the Same In force · High confidence | In force | High confidence | |
| US 12,766,121 | Method for Treating And/Or Preventing Epilepsy and Reducing Side Effect of Anti-Epileptic Drug by Using Cynarin In force · High confidence | In force | High confidence |
Also on record, not counted in the 10: 5 patents ended · 8 applications pending · 9 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.